Avg closing price
Price range

28 Ken Griffin Fate Therapeutics Trades

Ken Griffin's position in Fate Therapeutics is currently worth $19.6 Million. That's 0.02% of their equity portfolio (826th largest holding). The investor owns 2.65% of the outstanding Fate Therapeutics stock. The first Fate Therapeutics trade was made in Q4 2015. Since then Ken Griffin bought shares 34 more times and sold shares on 34 occasions. The investor's estimated purchase price is $51.5 Million, resulting in a loss of 62%.

Avg closing price
Price range
Increased shares by 32.0% (+647 Thousand shares) Q4 2023
Avg closing price $2.36
Price range $1.65 - $3.94
Sold 11.5% shares (-263 Thousand shares) Q3 2023
Avg closing price $3.31
Price range $2.02 - $5.04
Increased shares by 37.6% (+624 Thousand shares) Q2 2023
Avg closing price $5.52
Price range $4.76 - $6.59
Increased shares by 16.6% (+237 Thousand shares) Q1 2023
Avg closing price $6.03
Price range $4.24 - $11.12
Increased shares by 261.6% (+1.03 Million shares) Q4 2022
Avg closing price $18.78
Price range $9.86 - $23.83
Increased shares by 11.7% (+41.1 Thousand shares) Q3 2022
Avg closing price $28.89
Price range $21.04 - $36.06
Sold 16.1% shares (-67.7 Thousand shares) Q2 2022
Avg closing price $27.59
Price range $17.78 - $42.39
Increased shares by 143.9% (+248 Thousand shares) Q1 2022
Avg closing price $38.72
Price range $29.67 - $60.28
Sold 3.8% shares (-6.78 Thousand shares) Q4 2021
Avg closing price $56.68
Price range $47.84 - $64.34
Sold 73.9% shares (-508 Thousand shares) Q3 2021
Avg closing price $78.44
Price range $59.27 - $95.73
Sold 18.5% shares (-156 Thousand shares) Q2 2021
Avg closing price $80.58
Price range $67.25 - $92.52
Sold 67.5% shares (-1.75 Million shares) Q1 2021
Avg closing price $95.82
Price range $72.16 - $117.40
Sold 20.9% shares (-686 Thousand shares) Q3 2020
Avg closing price $34.92
Price range $30.41 - $40.50
Increased shares by 44.5% (+1.01 Million shares) Q2 2020
Avg closing price $29.80
Price range $20.21 - $35.23
Increased shares by 168.2% (+1.42 Million shares) Q1 2020
Avg closing price $25.29
Price range $17.28 - $31.88
Increased shares by 47.3% (+272 Thousand shares) Q4 2019
Avg closing price $15.88
Price range $13.39 - $20.73
New holding (+574 Thousand shares) Q3 2019
Avg closing price $19.17
Price range $15.47 - $22.50
Sold -870 Thousand shares Q2 2019
Avg closing price $18.02
Price range $15.61 - $20.44
Sold 29.8% shares (-369 Thousand shares) Q1 2019
Avg closing price $15.78
Price range $13.15 - $18.71
Increased shares by 57.7% (+453 Thousand shares) Q4 2018
Avg closing price $13.94
Price range $11.48 - $16.98

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!